Trials / Unknown
UnknownNCT01350687
Pulmonary Hypertension Prevention in Hemodialysis
New Phosphore Binders in Prevention of Pulmonary Hypertension
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (estimated)
- Sponsor
- The Baruch Padeh Medical Center, Poriya · Other Government
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Pulmonary hypertension is a new complication described in hemodialysis patients. in the last year these patients were treated by calcium carbonate orally to control serum phosphor. Calcium phosphor deposits in pulmonary artery can explain this phenomena. The investigators want to investigate the new phosphor non calcium containing agents in hemodialysis patients and to measure the pulmonary pressure.
Detailed description
The investigators will measure pulmonary blood pressure before and after treatment with new phosphor binders, non calcium containing.
Conditions
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2013-06-01
- Completion
- 2014-06-01
- First posted
- 2011-05-10
- Last updated
- 2011-05-10
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01350687. Inclusion in this directory is not an endorsement.